Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, biofeedback therapy significantly increases bowel frequency in adults with chronic constipation, adding about 1.6 bowel movements per week on average.
Biofeedback therapy is an effective, non-invasive treatment that improves defecation frequency and reduces symptoms for people with chronic constipation.
Yes, a postmarketing study in Japan found elobixibat improved constipation in patients with depression, with few side effects.
Research suggests a link between gut bacteria and uveitis through a concept called the "gut-eye axis," where an imbalance in gut microbes may trigger immune responses that affect…
Yes, early evidence suggests transcutaneous auricular vagus nerve stimulation may improve symptoms in some gastrointestinal disorders, especially constipation-predominant IBS…
In athletes, Bifidobacterium longum BB536 did not significantly improve gastrointestinal symptoms overall, though some benefits were seen in specific subgroups.
EGCG shows promise for treating fatty liver and other digestive diseases in animal and lab studies, but human trials are still needed to confirm its effectiveness.
Yes, quercetin and apigenin show promise for NAFLD by reducing liver fat and inflammation, but most evidence comes from lab and animal studies; human trials are limited.
Yes, gut metabolites like short-chain fatty acids and bile acids are linked to obesity and fatty liver, with dysbiosis driving inflammation and metabolic dysfunction.
Yes, robot-assisted esophagectomy reduces blood loss and hospital stays compared to conventional minimally invasive approaches for esophageal cancer, based on systematic reviews.
Yes, machine learning models can predict anastomotic leaks in gastric cancer patients with good accuracy, especially when using postoperative indicators and immunonutritional…
Yes, EGCG shows therapeutic effects against gastric cancer in lab and animal studies by inhibiting cell growth, inducing apoptosis, and altering immune signals, but human trials…
Yes, multiple phytochemicals from plants like Schisandra chinensis, oysters, and Artemisia stechmanniana show protective effects in animal models of alcoholic liver disease by…
The aMAP risk score is associated with increased mortality in patients with alcohol-related liver disease.
Gut microbiota imbalances, including harmful bacteria like Fusobacterium nucleatum, can promote colorectal cancer through inflammation, DNA damage, and immune disruption, while…
A maximum appendiceal diameter of 10.5 mm or greater helps diagnose complicated appendicitis, though a larger cutoff of 14.5 mm is also noted in other research.
Yes, mutations in KIT and PDGFRA genes, as well as germline variants near SLC6A18 and TERT, are linked to higher recurrence risk in GIST.
Yes, plozasiran reduces the risk of recurrent pancreatitis in severe hypertriglyceridemia by 83% based on a post hoc analysis of the PALISADE trial.
Yes, obinutuzumab has shown promise in case reports and small studies for FSGS patients who did not respond to rituximab, but larger trials are needed.
Yes, a phase II trial found chiglitazar significantly reduced liver fat in MASLD patients with high triglycerides and insulin resistance.
No, an R1 vascular margin is not considered acceptable for colorectal liver metastases in minimally invasive surgery due to higher local recurrence rates compared to R0 resection.
Yes, minimally invasive surgical thermal ablation (MITA) improves safety for colorectal liver metastases, with low major complication rates and very low mortality.
R1 vascular margins are not considered safe for colorectal liver metastases, as they are linked to higher local recurrence rates compared to R0 resections.
Research suggests natural herbal plants can target autophagy pathways in Metabolic-Associated Fatty Liver Disease, offering a multi-target approach that may be safer than…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.